{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:36:37Z","timestamp":1777602997207,"version":"3.51.4"},"reference-count":28,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/mmr.2015.3791","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T07:39:43Z","timestamp":1431675583000},"page":"3667-3673","source":"Crossref","is-referenced-by-count":14,"title":["Myeloid-derived suppressor cells suppress CD4+ and CD8+ T cell responses in autoimmune hepatitis"],"prefix":"10.3892","volume":"12","author":[{"given":"HAIWEN","family":"LI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FU","family":"DAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QIONG","family":"PENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUIZHONG","family":"GAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JISHUN","family":"ZHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUNLING","family":"XIA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WANYUAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"issue":"Suppl 2","key":"key20180108020323_b1-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.21059","article-title":"Autoimmune hepatitis, from mechanisms to therapy","volume":"43","author":"Manns","year":"2006","journal-title":"Hepatology"},{"key":"key20180108020323_b2-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"Longhi","year":"2010","journal-title":"J autoimmun"},{"key":"key20180108020323_b3-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology"},{"key":"key20180108020323_b4-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.4049\/jimmunol.176.4.2152","article-title":"P2X7 receptors regulate NKT cells in autoimmune hepatitis","volume":"176","author":"Kawamura","year":"2006","journal-title":"J Immunol"},{"key":"key20180108020323_b5-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key20180108020323_b6-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coi.2010.01.021","article-title":"Myeloid-derived suppressor cell heterogeneity and subset definition","volume":"22","author":"Peranzoni","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"key20180108020323_b7-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2010-12-325753","article-title":"A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells","volume":"118","author":"Solito","year":"2011","journal-title":"Blood"},{"key":"key20180108020323_b8-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"871881e1","DOI":"10.1053\/j.gastro.2008.06.032","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway","volume":"135","author":"Haile","year":"2008","journal-title":"Gastroenterology"},{"key":"key20180108020323_b9-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/imr.12084","article-title":"Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?","volume":"255","author":"Goh","year":"2013","journal-title":"Immunol Rev"},{"key":"key20180108020323_b10-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coph.2009.06.014","article-title":"Therapeutic targeting of myeloid-derived suppressor cells","volume":"9","author":"Ugel","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"key20180108020323_b11-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"key20180108020323_b12-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/08820139.2012.673191","article-title":"Myeloid-derived suppressor cells and anti-tumor T cells: A complex relationship","volume":"41","author":"Monu","year":"2012","journal-title":"Immunol Invest"},{"key":"key20180108020323_b13-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1182\/blood-2010-06-287839","article-title":"Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13","volume":"116","author":"Highfill","year":"2010","journal-title":"Blood"},{"key":"key20180108020323_b14-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1479-5876-9-90","article-title":"Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines","volume":"9","author":"Lechner","year":"2011","journal-title":"J Transl Med"},{"key":"key20180108020323_b15-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/156800911796191024","article-title":"Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer","volume":"11","author":"Goedegebuure","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180108020323_b16-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"key20180108020323_b17-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00432-009-0634-0","article-title":"Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+\/CD14 (-)\/CD15+\/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer","volume":"136","author":"Liu","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180108020323_b18-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.4049\/jimmunol.1103553","article-title":"Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release","volume":"188","author":"Jayaraman","year":"2012","journal-title":"J Immunol"},{"key":"key20180108020323_b19-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/ijc.28622","article-title":"Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways","volume":"134","author":"Raber","year":"2014","journal-title":"Int J Cancer"},{"key":"key20180108020323_b20-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2010.03.011","article-title":"Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma+vaccination model","volume":"223","author":"Jia","year":"2010","journal-title":"J Neuroimmunol"},{"key":"key20180108020323_b21-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1172\/JCI45862","article-title":"Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice","volume":"121","author":"Lu","year":"2011","journal-title":"J Clin Invest"},{"key":"key20180108020323_b22-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J Immunol"},{"key":"key20180108020323_b23-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.1101816","article-title":"Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease","volume":"188","author":"Ioannou","year":"2012","journal-title":"J Immunol"},{"key":"key20180108020323_b24-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaut.2008.08.006","article-title":"Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations","volume":"31","author":"Kerr","year":"2008","journal-title":"J Autoimmun"},{"key":"key20180108020323_b25-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.4049\/jimmunol.0903636","article-title":"Myeloid-derived suppressor cells prevent type 1 diabetes in murine models","volume":"185","author":"Yin","year":"2010","journal-title":"J Immunol"},{"key":"key20180108020323_b26-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaut.2009.08.006","article-title":"CD4 T cells in hepatic immune tolerance","volume":"34","author":"Carambia","year":"2010","journal-title":"J Autoimmun"},{"key":"key20180108020323_b27-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00430-010-0151-4","article-title":"Subsets, expansion and activation of myeloid-derived suppressor cells","volume":"199","author":"Ribechini","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"key20180108020323_b28-mmr-12-03-3667","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","article-title":"IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells","volume":"184","author":"He","year":"2010","journal-title":"J Immunol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3791\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T04:03:50Z","timestamp":1515384230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,5,15]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/mmr.2015.3791"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3791","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]}}}